Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) – Research analysts at Leerink Swann decreased their Q4 2016 earnings per share (EPS) estimates for Vertex Pharmaceuticals in a research report issued on Friday. Leerink Swann analyst G. Porges now anticipates that the firm will earn $0.16 per share for the quarter, down from their prior forecast of $0.22. Leerink […]
